Beste Online-Konsultation mit Hämatologen Onkologen - TOP-33 Ärzte

Mustafa Solak, MD, ist ein Arzt, der seinen Abschluss an der Medizinischen Fakultät der Hacettepe-Universität gemacht hat und Aufenthalte am Lehr- und Forschungskrankenhaus Istanbul Sisli Etfal und ein Stipendium am Krebsinstitut der Hacettepe-Universität absolviert hat. Er ist spezialisiert auf Brustkrebs, Hodenkrebs, Eierstockkrebs, Lungenkrebs, Kopf-Hals-Krebs und Magen-Darm-Krebs. Er hat auch am MD Anderson Cancer Center der University of Texas, dem Corum Training Hospital der Hitit University und dem Medical Park Hospital gearbeitet.

Education and Career

2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

2023 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Associate Professor

2013 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Specialist

2008 – 2013 Private Medical Park Fatih Hospital, General Surgery Specialist - Deputy Chief Physician

2005 – 2007 Private Gelişim Hospital – General Surgery Specialist

2003 – 2005 Private Istanbul Şafak Hospital – General Surgery Specialist - Chief Physician

2002 – 2003 ISTANBUL HASEKİ EDUCATION AND RESEARCH HOSPITAL – General Surgery Clinic Assistant Physician

1998 – 2002 Ankara Education and Research Hospital – General Surgery Clinic Assistant Physician

1998 – Health Sciences University – Istanbul Haseki Health Application and Research Center – Medical Specialization

1991 – Gazi University Faculty of Medicine – Bachelor’s Degree

Certificates

IGM Diagnosis, Treatment Workshop, Granulomatous Mastitis, Kocaeli, Certificate, 07.10.2023 (National)

ibreast 51- Free Flap Reconstruction, Breast Cancer Surgery, Online, Certificate, 30.09.2023 – 30.09.2023 (International)

ibreast 50- Triple Negative Breast Cancer, Breast Cancer, Online, Certificate, 02.09.2023 -02.09.2023 (International)

ibreast 49- Implant Based Reconstruction, Breast Cancer, Online, Certificate, 12.08.2023 -12.08.2023 (International)

ibreast 48- DCIS, İbreast 48- DCIS, Online, Certificate, 15.07.2023 -15.07.2023 (International)

ibreast 47- Conference Updates, Breast Cancer, Online, Certificate, 25.06.2023 -25.06.2023 (International)

ibreast 46- Margin Revisited, Breast Cancer, Online, Certificate, 10.06.2023 -10.06.2023 (International)

1. International 4. National Breast Surgery Congress, Breast Surgery, Ürgüp, Certificate, 05.05.2023 – 07.05.2023 (International)

ibreast 44- HER2 Positive Disease, Breast Cancer, Online, Certificate, 29.04.2023 -29.04.2023 (International)

St-Gallen 2023, St-Gallen Congress Summary Meeting, Istanbul, Certificate, 01.04.2023 -01.04.2023 (National)

ibreast 43- Save The Nipple, Breast Cancer, Online, Certificate, 25.03.2023 -25.03.2023 (International)

ibreast 42-Chest Wall Perforator Flap Revisited, Breast Cancer, Online, Certificate, 25.02.2023 -25.02.2023 (International)

ibreast 41- High Risk And B3 Lesions, Breast Diseases, Online, Certificate, 28.01.2023 -28.01.2023 (International)

15. New Approaches in Breast Cancer Education Meeting, Breast Cancer, Istanbul, Certificate, 07.01.2023 – 08.01.2023 (National)

Articles she wrote and took part in;

1.YILDIRIM EMİNE, BEKTAŞ SİBEL, YETİŞ FIRAT, YILDIZ EREN OZAN, ÖZDEMİR MUHAMMED, KOMUT NESLİHAN, ÇALIK MUSTAFA, ER AHMET MUZAFFER. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer. Annali Italiani di Chirurgia, 2023

2.UZUN NEDİM, YILDIRIM EMİNE. Relationship Between Toilet Type and Hemorrhoids. Bezmialem Vakif University, 2022

3.YILDIZ EREN OZAN, YILDIRIM EMİNE, ORHUN ERDOĞAN KIVILCIM, ERYILMAZ İKLİL, YÜNLÜEL EMİR MEHMET, YETİŞ FIRAT, ULUKENT SUAT CAN. The effect of the covid 19 pandemic on the number of patients treated for acute and complex acute appendicitis. Annali Italiani di Chirurgia, 2202

4.YILDIRIM EMİNE, BEKTAŞ SİBEL, ÖZDEMİR MUHAMMED, KARAGÜLLE AHENK, ER AHMET MUZAFFER, UÇAR NEŞE. Upgrade Rates of DCIS, Intraductal Papilloma, and the Other High-risk Breast Lesions. Hamidiye Medical Journal, 2022
 

5.ÖZKAN GÜMÜŞKAYA PERİHAN, ALTUN ÖZGÜR, KARAKÜTÜK YÜZTAŞ NUR, ÖZSOY NESLİHAN, AYDIN TUTAK GÜLTEN, YILDIRIM EMİNE, ADAŞ MİNE, KÜÇÜK MEHMET. COVID-19 Pnömonisi Sonrası AntiHBs Değerlerindeki Değişiklikler. Journal of Contemporary Medicine, 2022;12(4), 

6.KOMUT NESLİHAN, BEKTAŞ SİBEL, YILDIRIM EMİNE. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022 Jun;58:151933. 

7.KAYADİBİ YASEMİN, UÇAR NEŞE, AKAN YEŞİM NAMDAR, KAYA MEHMET FATİH, YILDIRIM EMİNE, ALADAĞ KURT SEDA, SOYLU BOY FATMA NUR, TAŞKIN FÜSUN, İÇTEN GÜL ESEN. Magnetic resonance imaging findings associated with recurrence in idiopathic granulomatous mastitis. Clinical Imaging, 2022

8.YILDIRIM EMİNE, KEĞİN MURAT, ÖZDEMİR MUHAMMED, BEKTAŞ SİBEL, PELEN ZEKERİYA, ER AHMET MUZAFFER. Neoplasms of theAppendix; Single Institution and Ten-Year Experiences Results. Turkish Journal of Trauma and Emergency Surgery, 2022;28(3), 352-360

9.YILDIRIM EMİNE, YILDIZ EREN OZAN, ERYILMAZ İKLİL, ER AHMET MUZAFFER, BEKTAŞ SİBEL. Comparison of excised breast volume, re-excision rate and margin positivity in breast-conserving surgery in breast cancer patients using and not using neoadjuvant chemotherapy. Journal of Surgery in Medicine,2022;6

10.YILDIRIM EMİNE, BEKTAŞ SİBEL, PELEN ZEKERİYA, YANIK İREM, ER AHMET MUZAFFER, ÇENGEL FERHAT, ÖZKAN GÜMÜŞKAYA PERİHAN. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. Journal of Gastrointestinal Cancer, 2022;53(1)

11.KAYADİBİ YASEMİN, KOÇAK BURAK, UÇAR NEŞE, AKAN YEŞİM NAMDAR, YILDIRIM EMİNE, BEKTAŞ SİBEL. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. Academic Radiology, 2022;29(1), 126-134.

12.YILDIRIM EMİNE, UÇAR NEŞE, YETİŞ FIRAT, KAYADİBİ YASEMİN, BEKTAŞ SİBEL. Diagnostic performance of breast imaging with ultrasonography, magnetic resonance and mammography in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Journal of Surgery and Medicine, 2022;6(1), 43-48

13.YILDIRIM EMİNE, BEKTAŞ SİBEL, GÖKTAŞ AYDIN SABİN, ER AHMET MUZAFFER, YANIK İREM, ÖZKAN GÜMÜŞKAYA PERİHAN, YILMAZ BARBAROS UTKU, BİLİCİ AHMET, ÖNCEL MUSTAFA. Factors Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2022;85(1), 41-50. 

14.YILDIRIM EMİNE, Pelen Zekeriya, KEĞİN MURAT, UÇAR NEŞE, KAYADİBİ YASEMİN, GÜNDOĞAR ÖZGECAN. Evaluation of the Reliability of Preoperative Ultrasonography and Ultrasonography-Guided Fine Needle Aspiration Biopsy in Axillary Staging in Patients With Breast Cancer. Journal of Academic Research in Medicine, 2021;11(3), 269-276., 

15. KAYADİBİ YASEMİN, UÇAR NEŞE, KAYA MEHMET FATİH, YILDIRIM EMİNE, BEKTAŞ SİBEL. Characterization of Suspicious Microcalcifications on Mammography Using 2D Shear-Wave Elastography. Ultrasound in Medicine & Biology, 2022;47(9), 2532-2542. 

16.KAYADİBİ YASEMİN, TEKCAN ŞANLI DENİZ ESİN, UÇAR NEŞE, YILDIRIM EMİNE, ŞANLI AHMET NECATİ. Evaluation of the Appearance Characteristics of Suspicious Microcalcifications Detected by Ultrasonography. Journal of Academic Research in Medicine, 2022;11(2), 199-205. 

17.YILDIRIM EMİNE, ÖZER HİLAL, ÖZER İLTER, KOYUNCU ADİL, YILDIRIM TİMUR. The Effects on Bacterial Translocation and Tissue Damage of Selenium Treatment in an Experimental Intestinal Ischaemia-Reperfusion Model. Turkish Journal of Trauma and Emergency Surgery, 2021;27(4), 389-394. 

18.YILDIRIM EMİNE, AKBAŞ PELİN, ORHUN ERDOĞAN KIVILCIM, BEKTAŞ SİBEL, ÖZKAN GÜMÜŞKAYA PERİHAN, ER AHMET MUZAFFER, PALTURA CEKİ. The comparison of the histopathological results of the thyroid fine-needle aspiration biopsies in the 795 patients with thyroidectomy. Diagnostic Cytopathology, 2021

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Dr. Dror Levin ist leitender Kinderarzt und Direktor der Behandlungsabteilungen für Blutkrankheiten und Knochenkrebs (Sarkom) im Kinderkrankenhaus „Dana“ bzw. im medizinischen Zentrum „Sourasky“. Er ist Facharzt für Kindermedizin, Hämatologie und Onkologie und hat zusätzliche Auslandserfahrung am Orthopädischen Institut Rizzoli in Italien.

Dr. hat ein Medizindiplom von der Uludağ University Medical College, Bursa, Türkei (1983), ein Postdoktorandenstipendium in Thermoradiotherapie von der Thomas Jefferson University, Philadelphia, PA (1990-1994) und eine Facharztausbildung in Radiation Oncology vom Center of Oncology & Nuclear Medizin, Istanbul, Türkei (1990). Er hatte auch Positionen als Professor, Vorsitzender und Koordinator für die Akkreditierung der Fakultät am Uludağ University Medical College (1991-2005), Professor und Direktor am Anadolu Medical Center (2004-2017) und Direktor am Ceylan International Hospital und am Medicana Bursa Hospital (2017) inne -gegenwärtig).

Lizenzierter Radioonkologe mit 8 Jahren medizinischer Ausbildung, einschließlich Grundstudium an der Medizinischen Fakultät der Marmara-Universität (2004-2011) und Spezialisierung auf Radioonkologie an der Medizinischen Fakultät der Marmara-Universität (2012-2016). Frühere Ausbildung an der Sixteen Numbered Shirvan School (Aserbaidschan) High School (1998-2004).

Dr. Raj ist ein sehr erfahrener chirurgischer Onkologe mit 19 Jahren Erfahrung und über 50.000 durchgeführten Krebsoperationen. Er ist an zahlreichen klinischen Studien beteiligt und hat viele internationale und nationale Veröffentlichungen zu seinem Verdienst. Er ist spezialisiert auf Brust- und Thorax-Chirurgie-Onkologie und Professor für DNB Superspecialty Surgical Oncology and Breast Surgery an der Maharashtra University of Health Sciences. Sein Glaube ist, „den Jahren Leben hinzuzufügen“ und die Lebensqualität zu verbessern, nicht nur dem Leben Jahre hinzuzufügen.

Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.

He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977. 

In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa. 

Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University. 

Current Positions: 

• .Since 1997, he is the Director of the Department of Medical Oncology and Haematology, at Istituto Clinico Humanitas, Milan. Also, he is Member of the Ethics Committee of Istituto Clinico Humanitas and Director of Clinical Research in the same Institute since 2007.
• - Since 2008, he is Member of the Planning Committee, Ministry of Work and of Health and Social Politics, Rome, Italy.
• - Since October 2008, Professor Santoro is Counsellor of the Board of Directors of the Fondazione Humanitas for Research of Rozzano, Italy.
• - Since November 2008, he is Expert Member of the National Centre for the Prevention and Control of Disease, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, he is National Representative preparatory actions for the "European Partnership for Action against Cancer" Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, Professor Santoro is member of National Italian Committee on the Research Network in Oncology, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since May 2009, he is Coordinator of the Oesophageal-Stomach Cancer Group Coordinator of the Liver and Biliary Tree Cancer Group, Regional Oncology Commission – Lombardy Oncology Network.

In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009). 

Publications: santoro%a - Search Results - PubMed (nih.gov) 

Dr. Alrawi ist ein hochqualifizierter und erfahrener, vom Vorstand zertifizierter chirurgischer Onkologe mit Fachkenntnissen in den Bereichen oberer Gastrointestinaltrakt, Kopf-Hals-Onkologie, minimalinvasive Onkologie, Brust-, kolorektale und beheizte Chemoperfusionsonkologie. Er hatte Positionen in tertiären Krebszentren inne und ist derzeit Direktor der Onkologiedienste im VPS-Krankenhaussystem in den VAE und MENA. Er ist auch in der onkologischen Forschung tätig.

Dr. X ist ein medizinischer Onkologe mit über 30 Jahren Erfahrung. Er hat eine medizinische Ausbildung von der Universität Istanbul, Spezialisierung auf Innere Medizin, und eine Spezialisierung auf medizinische Onkologie vom Institut für Onkologie der Universität Istanbul. Er ist Mitglied der Medical Oncology Association, Lung Cancers Association, ESMO, ASCO und Istanbul Medical Chamber.

Spezialist für medizinische Onkologie mit Expertise in Lungen-, Brust-, Darm-, Magen-, Leber-, Nieren-, Bauchspeicheldrüsen-, Magen-, Prostata- und Gebärmutterkrebs. Erfahrung in Chemotherapie, Immuntherapie, Phytotherapie, Ozontherapie, hyperthermischer Chemotherapie, GIS-Krebs sowie gynäkologischem und Urogenitalkrebs. Mitglied der Turkish Oncology Group, Medical Oncology Association, Turkish Cancer Research and Warfare Association, European Society of Medical Oncology, European Society of Gynecologic Oncology und International Association for the Study of Lung Cancer.

Dr. X hat einen Bachelor of Medicine von der Mysore University, Indien und einen Doktor der Medizin in Strahlentherapie von der Banaras Hindu University, Indien. Er ist Diplomat des National Board of Examination und Mitglied der Association of Radiation Oncology of India, der Society for Neuro-Oncology, der Bangalore Oncology Group und der Indian Association of Hyperthermia Oncology.